Core Viewpoint - Rosen Law Firm is reminding investors who purchased PomDoctor Ltd. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The class action lawsuit has been filed against PomDoctor Ltd. for misleading statements and fraudulent activities during the Class Period from October 9, 2025, to December 11, 2025 [4] - Investors who purchased PomDoctor securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][2] - The deadline to move the Court to serve as lead plaintiff is April 7, 2026, and a lead plaintiff acts on behalf of other class members [2] Group 2: Allegations Against PomDoctor - The lawsuit alleges that PomDoctor was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [4] - It is claimed that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign, which was not disclosed in PomDoctor's public statements [4] - The positive statements made by PomDoctor regarding its business and operations were deemed materially misleading due to the omission of critical information about false rumors and artificial trading activity [4] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [3] - The firm was ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability and success in this area [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Picard Medical, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on April 13, 2026 [1] Group 1: Class Action Details - Investors who bought Picard Medical securities between September 2, 2025, and October 31, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - Investors wishing to serve as lead plaintiff must file with the Court by April 13, 2026 [3] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4] Group 3: Case Allegations - The lawsuit alleges that defendants made materially false and misleading statements and failed to disclose adverse facts about Picard's business and operations [5] - Specific allegations include involvement in a fraudulent stock promotion scheme, insider trading through offshore accounts, and omission of critical information regarding stock price manipulation [5]

Industry Overview - Global EV registrations fell 3% year-over-year to about 1.2 million units in January 2026, with China experiencing a 20% decline to 600,000 units, the lowest in almost two years [2] - North American registrations dropped 33% to just over 85,000, while Europe saw a 24% increase to around 320,000, marking the smallest growth since February 2025 [2] - Carmakers with high U.S. exposure wrote down $55 billion last year due to weak demand and market complexities [2] - Registrations in the rest of the world surged 92% to just under 190,000, driven by incentives in Thailand and growth in South Korea and Brazil [2] - Global EV sales are expected to reach 24.3 million units in 2026, a 12% increase from 2025, but growth is slowing due to waning regulatory support [3] - U.S. sales fell 41% year-over-year in November 2025, with a predicted 15% decline in 2026 [3] - Industry executives warn of near-term challenges, with a "U.S. EV winter" anticipated and China's growth expected to slow after the removal of tax benefits [4] Company Highlights EnerSys (NYSE:ENS) - EnerSys is recognized as a promising stock, with Roth Capital raising its price target to $208 from $164 while maintaining a Buy rating [10] - The company recently expanded its DataSafe HX range for UPS systems, introducing new batteries designed for high-rate discharges and quick recharge capabilities [11][12] - The new batteries offer improved performance and compatibility with existing systems, enhancing flexibility for data center applications [13][14] MP Materials Corp. (NYSE:MP) - MP Materials is also highlighted as a promising stock, with JPMorgan raising its price target to $76 from $74 while maintaining an Overweight rating [15] - The company plans to build a massive campus for rare earth magnet production, expected to contribute to an annual output of about 10,000 metric tons [16][17] - This $1.25 billion investment aims to enhance domestic production capacity and create over 1,500 direct jobs, bolstering the U.S. rare earth magnet industry [17][18] - MP Materials operates the Mountain Pass rare earth mine, supplying key materials essential for EV batteries and supporting the transition to clean energy [19]

Walmart Inc. (NASDAQ:WMT) is included among the 13 Best March Dividend Stocks to Buy. Walmart (WMT) Coverage Reinstated With Bullish Outlook from BofA Niloo / Shutterstock.com On February 27, BofA reinstated coverage of Walmart Inc. (NASDAQ:WMT) with a Buy rating. The firm set a price target of $150 on the stock. The analyst said Walmart continues to gain market share, especially among higher-income consumers, helped by faster delivery options. At the same time, the company remains competitive with lowe ...

Chubb Limited (NYSE:CB) is included among the 13 Best March Dividend Stocks to Buy. Chubb (CB) Price Target Raised Following Property and Casualty Sector Results Photo by Dan Dennis on Unsplash On February 26, Morgan Stanley analyst Bob Huang raised his price recommendation on Chubb Limited (NYSE:CB) to $330 from $310. The firm kept an Equal Weight rating on the shares. The update came after reviewing fourth-quarter results across the property and casualty insurance sector. The analyst said insurers wit ...

Domino’s Pizza, Inc. (NASDAQ:DPZ) is included among the 13 Best March Dividend Stocks to Buy. BofA Cuts Domino’s (DPZ) Target to $545 While Keeping Bullish Rating On February 25, BofA lowered its price recommendation on Domino’s Pizza, Inc. (NASDAQ:DPZ) to $545 from $556. It reiterated a Buy rating on the shares. The analyst said the firm reduced its fiscal year EPS forecast to $19.99 from $20.31, mainly due to a higher expected tax rate. The adjustment came after reviewing the company’s latest earnings ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Enphase Energy, Inc. securities between April 22, 2025, and October 28, 2025, of the April 20, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Enphase securities during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][5]. - The lead plaintiff must file a motion with the court by April 20, 2026, to represent other class members in the litigation [2]. Group 2: Law Firm Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3]. Group 3: Case Allegations - The lawsuit alleges that Enphase made false and misleading statements regarding its ability to manage channel inventory and mitigate the effects of the termination of the Residential Clean Energy Credit [4]. - It is claimed that Enphase overstated its financial and operational prospects, leading to materially false public statements [4]. - The lawsuit asserts that when the true information became public, investors suffered damages [4].

Alcoa Corporation (NYSE:AA) is included among the 13 Best March Dividend Stocks to Buy. BofA Adjusts Alcoa (AA) Target Following Updated Metal Price Forecasts On February 26, BofA analyst Lawson Winder raised the firm’s price recommendation on Alcoa Corporation (NYSE:AA) to $42 from $38. The analyst kept an Underperform rating on the shares. The analyst said the update reflects revised forecasts for metal prices in 2026. As those assumptions changed, the firm adjusted its valuation outlook across North A ...

Nordic American Tankers Limited (NYSE:NAT) is included among the 13 Best March Dividend Stocks to Buy. Analyst Raises Nordic American Tankers (NAT) Price Target Following Earnings On February 27, B. Riley analyst Liam Burke raised his price recommendation on Nordic American Tankers Limited (NYSE:NAT) to $7.50 from $5. The analyst reiterated a Buy rating on the stock. The move followed the company’s latest earnings report and improving outlook for tanker rates. Nordic American Tankers released its Q4 202 ...

PPL Corporation (NYSE:PPL) is included among the 13 Best March Dividend Stocks to Buy. PPL Gets Upgrade from Barclays on Improving Earnings Visibility On February 24, Barclays upgraded PPL Corporation (NYSE:PPL) to Overweight from Equal Weight. The firm also raised its price target to $40 from $37. The analyst said the company is well-positioned for a “constructive” outcome in its Pennsylvania rate case. He also noted that PPL offers “increasingly visible” above-average earnings growth heading into 2026. ...